Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1452-1455, 2004. First published June 3, 2004; 10.1373/clinchem.2004.035352
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
clinchem.2004.035352v1
50/8/1452    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poon, T. C.W.
Right arrow Articles by Lo, Y.M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poon, T. C.W.
Right arrow Articles by Lo, Y.M. D.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2004;50:1452-1455.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Serial Analysis of Plasma Proteomic Signatures in Pediatric Patients with Severe Acute Respiratory Syndrome and Correlation with Viral Load

Terence C.W. Poon1,2,a, K.C. Allen Chan1,3, Pak-Cheung Ng1,4, Rossa W.K. Chiu1,3, Irene L. Ang1,2, Yu-kwan Tong1,3, Enders K.O. Ng1,3, Frankie W.T. Cheng4, Albert M. Li4, Ellis K.L. Hon4, Tai-Fai Fok4 and Y.M. Dennis Lo1,3

1 Centre for Emerging Infectious Diseases and Departments of2 Clinical Oncology,3 Chemical Pathology, and4 Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR

aaddress correspondence to this author at: Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing St., Shatin, New Territories, Hong Kong Special Administrative Region, China; e-mail tcwpoon@cuhk.edu.hk

The first 300 words of the full text of this article appear below.

An outbreak of severe acute respiratory syndrome (SARS) has affected 33 countries on five continents, with 8098 suspected and probable cases and 774 deaths. During the SARS epidemic, more than 1700 infected cases have been reported in Hong Kong. The disease is infectious, particularly within the healthcare setting. Early diagnosis is essential to control the spread of SARS by identifying and isolating infected patients (1)(2). Diagnostic tests have been developed that detect either antibodies to or reverse transcription-PCR (RT-PCR) products of the SARS coronavirus (SARS-CoV). SARS-CoV antibodies can be reliably detected only around 20 days after disease onset (3)(4). Quantitative real-time RT-PCR assays, on the other hand, allow the detection of SARS-CoV within the first week of illness. Our recent study showed that detection sensitivity could approach 80% for plasma and serum samples from SARS patients (5)(6). Aside from improving the analytical and clinical sensitivity of the RT-PCR assays, it is also possible to develop new types of assays on the basis of other biological variables and/or technologies. In the past few years, surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) has been applied to the discovery of diagnostic proteomic signatures for cancers such as prostate cancer, ovarian cancer, breast cancer, and hepatocellular carcinoma (7)(8). Here we report the presence of plasma proteomic signatures in serial blood samples from eight pediatric patients with SARS and their correlation with SARS-CoV RNA concentrations in plasma (6).

The serial plasma samples investigated in this study were those examined for SARS-CoV RNA by real-time RT-PCR in our recently reported study (6). The pediatric patients were admitted to the New Territories East Cluster of Hospital Authority Hospitals in Hong Kong and satisfied the WHO surveillance . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
R. T.K. Pang, T. C.W. Poon, K.C. A. Chan, N. L.S. Lee, R. W.K. Chiu, Y.-K. Tong, S. S.C. Chim, J. J.Y. Sung, and Y.M. D. Lo
Serum amyloid a is not useful in the diagnosis of severe acute respiratory syndrome.
Clin. Chem., June 1, 2006; 52(6): 1202 - 1204.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
R. T.K. Pang, T. C.W. Poon, K.C. A. Chan, N. L.S. Lee, R. W.K. Chiu, Y.-K. Tong, R. M.Y. Wong, S. S.C. Chim, S. M. Ngai, J. J.Y. Sung, et al.
Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome
Clin. Chem., March 1, 2006; 52(3): 421 - 429.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
A M Li and P C Ng
Severe acute respiratory syndrome (SARS) in neonates and children
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2005; 90(6): F461 - F465.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.